ACA App
Annals of Cardiac Anaesthesia Annals of Cardiac Anaesthesia Annals of Cardiac Anaesthesia
Home | About us | Editorial Board | Search | Ahead of print | Current Issue | Archives | Submission | Subscribe | Advertise | Contact | Login 
Users online: 1678 Small font size Default font size Increase font size Print this article Email this article Bookmark this page
Read this article

 


    Article Cited by others

LETTER TO EDITOR

Bosentan for the treatment of portopulmonary hypertension

Tempe Deepak K, Datt Vishnu, Datta Divesh

Year : 2008| Volume: 11| Issue : 2 | Page no: 139-140

   This article has been cited by
 
1 Portopulmonary hypertension
Yong Lv,Guohong Han,Daiming Fan
Scandinavian Journal of Gastroenterology. 2016; 51(7): 795
[Pubmed]  [Google Scholar] [DOI]
2 Three-dimensional pharmacophore modelling studies on antagonists of endothelin receptor ETA
Babu, V.S., Balaji, V.N., Viswanadhan, V.N., Chan, M.F., Phukan, S., Rao, S.N.
Current Science. 2011; 100(12): 1847-1855
[Pubmed]  [Google Scholar]
3 Non-congenital heart disease associated pediatric pulmonary arterial hypertension
Ivy, D.D., Feinstein, J.A., Humpl, T., Rosenzweig, E.B.
Progress in Pediatric Cardiology. 2009; 27((1-2)): 13-23
[Pubmed]  [Google Scholar]
4 Non-congenital heart disease associated pediatric pulmonary arterial hypertension
D.D. Ivy,J.A. Feinstein,T. Humpl,E.B. Rosenzweig
Progress in Pediatric Cardiology. 2009; 27(1-2): 13
[Pubmed]  [Google Scholar] [DOI]